Healthcare Sector

PFE

Market Tracker

$27.43
+0.82
(+3.08%)
5:40 am
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
03/27/2026 CALL $26.00 7,294 +7,033 +2,694.64%
03/20/2026 CALL $27.00 72,044 +5,685 +8.57%
04/17/2026 CALL $27.00 35,684 +3,290 +10.16%
03/20/2026 CALL $27.50 12,290 +1,992 +19.34%
03/27/2026 PUT $26.00 8,765 +1,559 +21.63%
03/20/2026 PUT $26.50 5,068 +1,142 +29.09%
12/17/2027 CALL $32.00 4,772 -146 -2.97%
01/21/2028 CALL $30.00 18,537 -161 -0.86%
01/15/2027 CALL $30.00 39,575 -177 -0.45%
12/17/2027 CALL $35.00 11,942 -201 -1.66%
03/20/2026 CALL $26.00 25,044 -226 -0.89%
03/20/2026 CALL $28.00 75,930 -614 -0.80%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • Pfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients

    03/17 10:39 am

    Benzinga

    Read more
  • Should You Avoid Pfizer? Here's the Key Risk to Watch

    03/17 01:15 am

    The Motley Fool

    Read more
  • Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

    03/16 07:19 am

    Benzinga

    Read more
  • Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

    03/16 07:00 am

    GlobeNewswire Inc.

    Read more
  • BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz

    03/10 02:49 pm

    Benzinga

    Read more
  • 2 Healthcare Stocks That Are Too Cheap to Ignore

    03/10 12:23 pm

    The Motley Fool

    Read more
  • BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

    03/10 08:40 am

    Benzinga

    Read more
  • Neumega (Pfizer, (Wyeth Pharmaceuticals)) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/10 05:53 am

    GlobeNewswire Inc.

    Read more
  • Pegasys (Roche, pharmaand) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/10 05:51 am

    GlobeNewswire Inc.

    Read more
  • Where Will Eli Lilly Stock Be in 10 Years?

    03/07 12:15 pm

    The Motley Fool

    Read more
  • Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks

    03/07 02:15 am

    The Motley Fool

    Read more
  • Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now

    03/06 10:15 pm

    The Motley Fool

    Read more
  • China Clears Weight-Loss Shot As Pfizer Enters Crowded Market

    03/06 09:14 am

    Benzinga

    Read more
  • Skeletal Dysplasia Market - Global Forecast 2026-2032: $5.37 Bn Opportunities Driven by Advancing Diagnostic Precision, Integrated Therapies, Evidence Generation, and Equitable Access

    03/05 05:51 am

    GlobeNewswire Inc.

    Read more
  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities

    03/04 06:48 am

    GlobeNewswire Inc.

    Read more
  • Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?

    03/03 04:14 pm

    The Motley Fool

    Read more
  • Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

    03/02 05:59 am

    GlobeNewswire Inc.

    Read more
  • Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need

    03/01 01:03 pm

    The Motley Fool

    Read more
  • Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole

    02/27 07:22 pm

    The Motley Fool

    Read more
  • A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

    02/27 03:52 pm

    GlobeNewswire Inc.

    Read more
  • One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

    02/27 01:31 pm

    GlobeNewswire Inc.

    Read more
  • PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

    02/26 02:35 pm

    GlobeNewswire Inc.

    Read more
  • Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership

    02/26 08:00 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know.

    02/25 03:15 pm

    The Motley Fool

    Read more
  • Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment

    02/25 02:22 pm

    Benzinga

    Read more
  • Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

    02/25 01:54 pm

    GlobeNewswire Inc.

    Read more
  • Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036

    02/25 10:00 am

    GlobeNewswire Inc.

    Read more
  • This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income

    02/24 10:30 am

    The Motley Fool

    Read more
  • Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot

    02/20 12:02 pm

    Benzinga

    Read more
  • Glucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies

    02/20 06:53 am

    GlobeNewswire Inc.

    Read more
  • Sexual Health Supplement Market Report 2026-2035: Market to Reach $5.31 Billion by 2030, Driven by Biotechnology Innovation, Transparency in Ingredient Traceability and Gender-Specific Expansion

    02/20 06:49 am

    GlobeNewswire Inc.

    Read more
  • Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

    02/18 06:55 am

    GlobeNewswire Inc.

    Read more
  • Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial

    02/17 11:15 am

    Benzinga

    Read more
  • Global Fibrin Sealant Market Size to Reach USD 3.57 Billion by 2035 with 8.37% CAGR – SNS Insider

    02/17 04:51 am

    GlobeNewswire Inc.

    Read more
  • Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider

    02/16 09:00 am

    GlobeNewswire Inc.

    Read more
  • What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?

    02/14 03:25 pm

    The Motley Fool

    Read more
  • Meet the 6.3% Yield Dividend Stock That Could Soar in 2026

    02/13 07:32 am

    The Motley Fool

    Read more
  • Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica

    02/10 06:55 am

    GlobeNewswire Inc.

    Read more
  • Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

    02/09 02:15 am

    GlobeNewswire Inc.

    Read more
  • Gute Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus

    02/09 02:15 am

    GlobeNewswire Inc.

    Read more
  • 3 Healthcare Stocks Paying the Highest Dividends of 2026

    02/06 04:15 pm

    The Motley Fool

    Read more
  • Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

    02/06 06:00 am

    GlobeNewswire Inc.

    Read more
  • Obesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally

    02/05 05:00 am

    GlobeNewswire Inc.

    Read more
  • Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

    02/05 04:57 am

    GlobeNewswire Inc.

    Read more
  • Will the Market Crash in 2026? Here's What History Says and What to Do About It

    02/04 12:15 am

    The Motley Fool

    Read more
  • Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off

    02/03 10:29 pm

    The Motley Fool

    Read more
  • Why Pfizer Stock Dropped Today

    02/03 12:16 pm

    The Motley Fool

    Read more
  • Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

    02/03 09:50 am

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: